HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
Omar Khan(Cancer Research UK Oxford Centre), Nicholas B. La Thangue(University of Oxford)
Cited by 443
Related Papers
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
|Nature Communications|2023|115
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism
|Cancer Research|2016|44
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
|Communications Biology|2023|16